Page last updated: 2024-08-16

rivastigmine and Vomiting

rivastigmine has been researched along with Vomiting in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (61.54)29.6817
2010's5 (38.46)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fan, D; Feng, T; Ji, Y; Jia, J; Kuang, W; Li, Y; Liang, Z; Ning, Y; Peng, D; Wei, W; Xiao, S; Ye, Q1
Deardorff, WJ; Grossberg, GT; Nieto, RA1
Bhatnagar, V; Brannan, S; Koumaras, B; Meng, X; Olin, JT; Reyes, P1
Darreh-Shori, T; Jelic, V1
Pregelj, P1
Aarsland, D; Albanese, A; Byrne, EJ; De Deyn, PP; Deuschl, G; Durif, F; Emre, M; Kulisevsky, J; Lane, R; Lees, A; Poewe, W; Quarg, P; Robillard, A; Rosa, MM; Tekin, S; van Laar, T; Wolters, E1
Harada, CN; Sachs, GA; Shega, JW1
Morgan, J; Sethi, KD1
Arciniegas, D; Chen, M; Gunay, I; Harvey, PD; Katz, DI; Koumaras, B; Mirski, D; Potkin, SG; Reyes, P; Silver, JM; Warden, D1
Burns, A; Charles, HC; Cummings, J; del Ser, T; Farlow, M; Feldman, HH; Ferris, S; Fox, NC; He, Y; Herrmann, N; Inzitari, D; Lane, R; Mancione, L; Orgogozo, JM; Potkin, S; Sauer, H; Scarpini, E; Scheltens, P; Sfikas, N; Tekin, S; Winblad, B1
Wesnes, K1
Landmark, K; Reikvam, A1
Allison, M; Appel-Dingemanse, S; Ho, YY; Huang, HL; Kiese, B; Lefèvre, G; Pommier, F; Sedek, G1

Reviews

2 review(s) available for rivastigmine and Vomiting

ArticleYear
Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia.
    Expert opinion on drug safety, 2010, Volume: 9, Issue:1

    Topics: Administration, Cutaneous; Administration, Oral; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dermatitis, Irritant; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome; Vomiting

2010
Rivastigmine tartrate with a focus on dementia associated with Parkinson's disease.
    Drugs of today (Barcelona, Spain : 1998), 2007, Volume: 43, Issue:6

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor; Vomiting

2007

Trials

6 trial(s) available for rivastigmine and Vomiting

ArticleYear
Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease.
    Journal of Alzheimer's disease : JAD, 2019, Volume: 72, Issue:4

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Female; Humans; Male; Middle Aged; Nausea; Rivastigmine; Severity of Illness Index; Treatment Outcome; Vomiting

2019
Rivastigmine for dementia associated with Parkinson's disease.
    The New England journal of medicine, 2004, Dec-09, Volume: 351, Issue:24

    Topics: Aged; Cholinesterase Inhibitors; Dementia; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor; Vomiting

2004
Rivastigmine for dementia associated with Parkinson's disease.
    Current neurology and neuroscience reports, 2005, Volume: 5, Issue:4

    Topics: Aged; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Female; Humans; Male; Mental Disorders; Middle Aged; Nausea; Neuroprotective Agents; Parkinson Disease; Patient Selection; Phenylcarbamates; Prospective Studies; Rivastigmine; Treatment Outcome; Tremor; Vomiting

2005
Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
    Neurology, 2006, Sep-12, Volume: 67, Issue:5

    Topics: Adolescent; Adult; Antiemetics; Benzamides; Brain Injuries; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Prospective Studies; Rivastigmine; Treatment Outcome; Vomiting

2006
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.
    The Lancet. Neurology, 2007, Volume: 6, Issue:6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Rivastigmine; Tremor; Vomiting

2007
Pharmacokinetics and bioavailability of the novel rivastigmine transdermal patch versus rivastigmine oral solution in healthy elderly subjects.
    Journal of clinical pharmacology, 2008, Volume: 48, Issue:2

    Topics: Administration, Cutaneous; Administration, Oral; Aged; Area Under Curve; Benzylamines; Biological Availability; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Cross-Over Studies; Dizziness; Female; Half-Life; Headache; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Phenethylamines; Phenols; Phenylcarbamates; Rivastigmine; Sleep Initiation and Maintenance Disorders; Solutions; Tandem Mass Spectrometry; Vomiting

2008

Other Studies

5 other study(ies) available for rivastigmine and Vomiting

ArticleYear
Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:6

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Humans; Nausea; Rivastigmine; Transdermal Patch; Vomiting

2016
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
    International journal of geriatric psychiatry, 2010, Volume: 25, Issue:4

    Topics: Activities of Daily Living; Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Antiparkinson Agents; Blood Pressure; Capsules; Cholinesterase Inhibitors; Cognition; Dizziness; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Humans; Incidence; Male; Memantine; Middle Aged; Nausea; Phenylcarbamates; Pilot Projects; Prospective Studies; Rivastigmine; Vomiting

2010
Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2012, Volume: 12, Issue:3

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dermatitis, Contact; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neuropsychological Tests; Patient Compliance; Phenylcarbamates; Prospective Studies; Rivastigmine; Transdermal Patch; Treatment Outcome; Vomiting

2012
Rivastigmine for dementia associated with Parkinson's disease.
    The New England journal of medicine, 2005, Mar-31, Volume: 352, Issue:13

    Topics: Bias; Cholinesterase Inhibitors; Data Interpretation, Statistical; Dementia; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor; Vomiting

2005
[Rivastigmine against dementia in Parkinson disease?].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2007, Nov-15, Volume: 127, Issue:22

    Topics: Cholinesterase Inhibitors; Dementia; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Vomiting

2007